Epidermal growth factor receptor (EGFR) expression in the serum of patients with triple-negative breast carcinoma: prognostic value of this biomarker

BACKGROUND: Epidermal growth factor receptor (EGFR) overexpression has been considered a poor prognostic factor in breast cancer. METHODOLOGY: A prospective study of 206 women with breast cancer analysed by stages (I, II, III and IV) and by immunohistochemical subtype (Luminal A, Luminal B, HER2+ an...

Descripción completa

Detalles Bibliográficos
Autores principales: de Araújo, Rogério Agenor, da Luz, Felipe Andrés Cordero, da Costa Marinho, Eduarda, Nascimento, Camila Piqui, de Andrade Marques, Lara, Delfino, Patrícia Ferreira Ribeiro, Antonioli, Rafael Mathias, Araújo, Breno Jeha, da Silva, Ana Cristina Araújo Lemos, dos Reis Monteiro, Maria Luiza Gonçalves, Neto, Morun Bernardino, Silva, Marcelo José Barbosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458269/
https://www.ncbi.nlm.nih.gov/pubmed/36158981
http://dx.doi.org/10.3332/ecancer.2022.1431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458269/
https://www.ncbi.nlm.nih.gov/pubmed/36158981
http://dx.doi.org/10.3332/ecancer.2022.1431

Ejemplares similares